Until now, the contribution of both STAT5 activation and DPF3 expression in patients with CLL was completely unknown and for the first time our study highlights the up-regulation of a STAT5 target gene and activation of STAT5 pathway in myeloid cells of CLL patients. This evidence concerns the gene DPF3 and B-cell chronic lymphocytic leukemia.